Firms
Logos Capital
- Founded
- —
- Type
- Venture capital
Team
No team members on record yet.
Co-investing
ARCH Venture Partners
Mirador Tx$250M · 2026-01-12Mirador Therapeutics$250M · 2025
Mirador Tx$400M · 2024-03-21
Maze Therapeutics$115M · 2024Rapport Therapeutics$150M · 2023-08-23
Rapport Therapeutics, Inc.$150M · 2023Rapport$150M · Unknown date
General Catalyst
Beacon Biosignals$86M · 2025-11
Elektrofi$112M · 2024-10-31
Elektrofi, Inc.$112M · 2024-10-31
Maze Therapeutics$115M · 2024
Alexandria Venture Investments
Mirador Therapeutics$250M · 2025
Mirador Tx$400M · 2024-03-21
Asher Bio$108M · 2021-09-01
Bain Capital
Annexon Biosciences$100M · 2020-07-01
Annexon Biosciences$100M · Unknown date
Angitia Biopharmaceuticals$130M · Unknown date
Catalio Capital Management
Beacon Biosignals$86M · 2025-11
Elektrofi$112M · 2024-10-31
Elektrofi, Inc.$112M · 2024-10-31
Cormorant Asset Management
Rapport Therapeutics$150M · 2023-08-23
Rapport Therapeutics, Inc.$150M · 2023Rapport$150M · Unknown date
Fidelity Management & Research Company
Mirador Tx$250M · 2026-01-12
Mirador Tx$400M · 2024-03-21Rapport$150M · Unknown date
T. Rowe Price
Rapport Therapeutics$150M · 2023-08-23
Rapport Therapeutics, Inc.$150M · 2023Rapport$150M · Unknown date
Venrock Healthcare Capital Partners
Mirador Tx$250M · 2026-01-12Mirador Therapeutics$250M · 2025
Angitia Biopharmaceuticals$130M · Unknown date
Adage Capital Management
Annexon Biosciences$100M · 2020-07-01
Annexon Biosciences$100M · Unknown date
Blackstone Life Sciences
Annexon Biosciences$100M · 2020-07-01
Annexon Biosciences$100M · Unknown date
Blue Owl Healthcare Opportunities
Mirador Tx$250M · 2026-01-12
Mirador Tx$400M · 2024-03-21
Casdin Capital
Beacon Biosignals$86M · 2025-11
Maze Therapeutics$115M · 2024
Deep Track Capital
Elektrofi$112M · 2024-10-31
Elektrofi, Inc.$112M · 2024-10-31
Eventide Asset Management
Annexon Biosciences$100M · 2020-07-01
Annexon Biosciences$100M · Unknown date
Farallon Capital Management
Mirador Tx$250M · 2026-01-12Mirador Therapeutics$250M · 2025
GV
Beacon Biosignals$86M · 2025-11
Maze Therapeutics$115M · 2024
LightspeedTriana Bio$110M · 2022-04-06
Gravity$30M · Unknown date
New Enterprise Associates
Annexon Biosciences$100M · 2020-07-01
Annexon Biosciences$100M · Unknown date
Sanofi Ventures
Mirador Therapeutics$250M · 2025
Mirador Tx$400M · 2024-03-21
Sofinnova Partners
Rapport Therapeutics, Inc.$150M · 2023Rapport$150M · Unknown date
SR One
Elektrofi$112M · 2024-10-31
Elektrofi, Inc.$112M · 2024-10-31
The Goldman Sachs Group, Inc.
Rapport Therapeutics$150M · 2023-08-23
Rapport Therapeutics, Inc.$150M · 2023
Wellington Management
Asher Bio$108M · 2021-09-01
Angitia Biopharmaceuticals$130M · Unknown date
Alumni Ventures
Beacon Biosignals$86M · 2025-11
Andreessen Horowitz
Maze Therapeutics$115M · 2024
Anthony Philippakis
Beacon Biosignals$86M · 2025-11
Atlas Venture
Triana Bio$110M · 2022-04-06
Braidwell LP
Elektrofi$112M · 2024-10-31
BVF Partners L.P.
Elektrofi, Inc.$112M · 2024-10-31
Elikon Venture
Angitia Biopharmaceuticals$130M · Unknown date
Fidelity Investments
Rapport Therapeutics$150M · 2023-08-23
Hemant Taneja
Beacon Biosignals$86M · 2025-11
Iaso Ventures
Beacon Biosignals$86M · 2025-11
Indicator Ventures
Beacon Biosignals$86M · 2025-11
Innoviva
Beacon Biosignals$86M · 2025-11
Mission BioCapital
Asher Bio$108M · 2021-09-01
Moore Strategic Ventures
Maze Therapeutics$115M · 2024
Morningside
Angitia Biopharmaceuticals$130M · Unknown date
Nexus NeuroTech Ventures
Beacon Biosignals$86M · 2025-11
Pfizer Ventures
Triana Bio$110M · 2022-04-06
RA Capital Management
Triana Bio$110M · 2022-04-06
S32
Beacon Biosignals$86M · 2025-11
Surveyor Capital
Triana Bio$110M · 2022-04-06
Synetro Group
Beacon Biosignals$86M · 2025-11
Takeda
Beacon Biosignals$86M · 2025-11
Third Rock Ventures
Asher Bio$108M · 2021-09-01
WEX Venture Capital
Gravity$30M · Unknown date
Y Combinator
Asher Bio$108M · 2021-09-01